Abbott

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Abbott 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ABT

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. 

CEO
Robert B. Ford
CEORobert B. Ford
Employees
115,000
Employees115,000
Headquarters
Abbott Park, Illinois
HeadquartersAbbott Park, Illinois
Founded
1888
Founded1888
Employees
115,000
Employees115,000

ABT Key Statistics

Market cap
171.53B
Market cap171.53B
Price-Earnings ratio
24.87
Price-Earnings ratio24.87
Dividend yield
2.73%
Dividend yield2.73%
Average volume
11.61M
Average volume11.61M
High today
$101.87
High today$101.87
Low today
$88.40
Low today$88.40
Open price
$95.21
Open price$95.21
Volume
22.21M
Volume22.21M
52 Week high
$137.49
52 Week high$137.49
52 Week low
$81.97
52 Week low$81.97

Stock Snapshot

As of today, Abbott(ABT) shares are valued at $98.48. The company's market cap stands at 171.53B, with a P/E ratio of 24.87 and a dividend yield of 2.73%.

During the trading session on 2026-07-16, Abbott(ABT) shares reached a daily high of $101.87 and a low of $88.40. At a current price of $98.48, the stock is +11.4% higher than the low and still -3.3% under the high.

Trading activity shows a volume of 22.21M, compared to an average daily volume of 11.61M.

Over the past 52 weeks, Abbott(ABT) stock has traded between a high of $137.49 and a low of $81.97.

Over the past 52 weeks, Abbott(ABT) stock has traded between a high of $137.49 and a low of $81.97.

ABT News

Benzinga 2h
Why Is Abbott Stock Skyrocketing Thursday? - Abbott Laboratories - Benzinga

...

Why Is Abbott Stock Skyrocketing Thursday? - Abbott Laboratories - Benzinga
Benzinga 2h
Abbott Brushes Off Procedure Volume Concerns, Lifts Outlook

Adjusted earnings came in at $1.31 per share, topping the analyst consensus estimate of $1.28. Revenue increased 13% year over year to $12.59 billion, ahead of...

Abbott Brushes Off Procedure Volume Concerns, Lifts Outlook
The Motley Fool 2h
Dow Jones Hangs On While Memory Chips Take Another Beating

The semiconductor sell-off that began Monday in Seoul extended into a fourth consecutive session on Thursday. The tech-heavy indexes lagged while the Dow nearly...

Dow Jones Hangs On While Memory Chips Take Another Beating

Analyst ratings

82%

of 28 ratings
Buy
82.1%
Hold
17.9%
Sell
0%

More ABT News

TipRanks 2h
Abbott Laboratories Stock Rallies on a Q2 Earnings Beat and a 2026 EPS Guidance Increase

Abbott Laboratories (ABT) stock was on the rise Thursday as investors reacted positively to the healthcare company’s Q2 2026 earnings report. That report includ...

TipRanks 3h
Abbott rises 10.7%

Abbott (ABT) is up 10.7%, or $9.56 to $98.83. TipRanks has entered a new arena in the investing world, powering the index of an ETF based on its unique data no...

MarketWatch 4h
Healthcare sector is having a moment, driven by strong earnings reports

Healthcare sector is having a moment, driven by strong earnings reports The healthcare sector is the day's strongest, with strong earnings from UnitedHealth an...

Healthcare sector is having a moment, driven by strong earnings reports
Benzinga 4h
Abbott Stock's Best Day Ever: +13.6% On Earnings Beat, Guidance Raise

A three-cent earnings beat and a narrow guidance raise unlocked the largest single-day advance the stock has ever recorded. Shares of Abbott Laboratories jumpe...

Abbott Stock's Best Day Ever: +13.6% On Earnings Beat, Guidance Raise
Investor's Business Daily 6h
Abbott Bounds Higher After Hiking 2026 Profit View On Second-Quarter Beat

Technology Abbott Bounds Higher After Hiking 2026 Profit View On Second-Quarter Beat Licensing Abbott Laboratories (ABT) stock jumped early Thursday after the h...

Abbott Bounds Higher After Hiking 2026 Profit View On Second-Quarter Beat
Seeking Alpha 6h
Abbott rises as guidance hike tops expectations

Abbott Laboratories (ABT) added ~3% in the premarket on Thursday after the MedTech giant boosted its full-year outlook ahead of Street estimates following a bet...

Abbott rises as guidance hike tops expectations
TipRanks 7h
Abbott raises FY26 adjusted EPS view to $5.45-$5.60 from $5.38-$5.58

FY26 consensus $5.48. Abbott (ABT) projects full-year 2026 comparable sales growth of 6.5% to 7.5%, consensus $50.26B. Published first on TheFly – the ultimate...

People also own

Based on the portfolios of people who own ABT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.